ABSTRACT
INTRODUCTION
Gynura procumbens is a tropical medicinal shrub widely used in various parts of Southeast Asia for traditional treatment of multiple ailments ranging from eruptive fever and rashes to cancer and diabetes (Perry 1980) . To date, this medicinal plant has been scientifically investigated for anti-herpetic (Jarikasem et al. 2013; Nawawi et al. 1999) , anti-hyperlipidaemic (Zhang & Tan 2000) , antihypertensive (Hoe at al. 2011 (Hoe at al. , 2007 Kim et al. 2006) , anti-cancer (Agustina et al. 2006; Hew et al. 2013; Nurulita et al. 2012) , anti-sterility (Pusparanee et al. 2008) , antiulcerogenic (Mahmood et al. 2010) , wound healing (Zahra et al. 2011) , anti-oxidative (Puangpronpitag et al. 2010; Rosidah et al. 2009 Rosidah et al. , 2008 , anti-hyperglycaemic (Akowuah et al. 2002 (Akowuah et al. , 2001 Algariri et al. 2013; Chong et al. 2012; Hassan et al. 2010 Hassan et al. , 2008 Lee et al. 2012) , anti-malarial (Visalini et al. 2012 ) and anti-inflammatory (Iskander et al. 2002) properties. The underlying mechanism and the bioactive components involved specifically for the last two activities have yet to be fully elucidated.
We have previously shown that LiCl, as a direct inhibitor of GSK3, suppressed parasitaemia development in a rodent malarial infection model (Nurul Aiezzah et al. 2010 ) and increased experimental animal survival in an acute melioidosis infection model (Tay et al. 2012) , thus implicating a role of this kinase in malarial and bacterial pathogenesis. GSK3 was first identified in 1980 as a serine/threonine kinase which phosphorylates and inactivates glycogen synthase (Embi et al. 1980) . In mammals, this protein is encoded by two highly related genes encoding GSK3α and GSK3β, respectively. GSK3 is an enzyme whose activity is inhibited by phosphorylation at Ser21 for GSK3α or Ser9 for GSK3β isoforms (Cross et al. 1995; Sutherland et al. 1993 ) and is active under basal conditions. Dysregulation of GSK3 activity is implicated in many diseases such as diabetes, Alzheimer and cancer (Eldar-Finkelman 2002; Eldar-Finkelman et al. 1999; Wang et al. 2011 ). The kinase is now known to play an important roles in diverse cellular processes such as protein synthesis, regulation of transcription factors, embryonic development, apoptosis, cell cycle control, cell differentiation, cell mobility, migration and as a central regulator of the inflammatory response to bacterial infections (Jope & Johnson 2004; Wang et al. 2014) .
It is noteworthy that preliminary studies using a yeast-based assay (Chong et al. 2012 ) detected GSK3-inhibitory activity in the aqueous extract prepared from G. procumbens absent in the ethanolic extract (unpublished data). This implicates the potential of the aqueous extract, like LiCl, to similarly affect Plasmodium parasite development via GSK3 inhibition. Coincidentally, kaempferol, a phytoconstituent in G. procumbens has been shown elsewhere to activate the PI3K/Akt pathway (Choi 2011; Lee et al. 2010) . Therefore, anti-plasmodial activity of G. procumbens could be attributed to inhibition of GSK3 either directly as in the case with LiCl; or indirectly through PI3K/Akt due to the action of kaempferol. Interestingly, kaempferol is also reported to exhibit glucose-lowering effects in soleus muscle mediated through PI3K/Akt pathway (Calderón-Montaño et al. 2011; Cazarolli et al. 2009; Zanatta et al. 2008) .
During bacterial infections, increased expression of Toll-like receptors results in overproduction of proinflammatory cytokines, which may lead to sepsis and fatality if untreated . GSK3β has been identified as a key component in the regulation of host inflammatory response through its control on the favourable balance between productions of pro-and antiinflammatory cytokines (Cortés-Vieyra et al. 2012; Wang et al. 2014) . The involvement of GSK3β in regulating host innate inflammatory response during bacterial infections has been reported in Salmonella typhimurium (Duan et al. 2007) and Francisella tularensis ) as well as in B. pseudomallei infections (Tay et al. 2012) . Inhibition of GSK3β through the phosphorylation at Ser9 residues in these infections increased the production of anti-inflammatory cytokines whilst production of proinflammatory cytokines was lowered (Cortés-Vieyra et al. 2012; Pramila et al. 2013; Zhang et al. 2009 ).
Therefore, based on the above reports and previous findings implicating involvement of GSK3β in G. procumbens effects, the present study aimed at investigating whether anti-malarial and anti-inflammatory effects of the aqueous extract of G. procumbens and kaempferol are mediated through inhibition of GSK3β.
MATERIALS AND METHODS

PLANT MATERIAL
G. procumbens leaves were collected from the Green House Facility, Faculty of Science and Technology (FST), Universiti Kebangsaan Malaysia (UKM). A voucher specimen (UKMB40195) was deposited at the herbarium in FST. Fresh leaves were washed, weighed and air-dried at room temperature for three to four weeks. Dried leaves were then ground into powder, weighed and macerated with 95% ethanol for three times. Each maceration involved three days of soaking at room temperature. The extract was filtered and residues completely air-dried at room temperature. The aqueous extract was prepared by further soaking of the dried residue for 24 h, filtering and freeze-drying (Labconco, USA) of the filtrate. The extract was then stored dry at -20°C until used for further experiments. Kaempferol (purity ≥ 97%) was purchased from Calbiochem, USA.
CULTURE OF P. FALCIPARUM
P. falciparum 3D7, purchased from the Malaria Research and Reference Reagent Resource Center (MR4, USA) was maintained in continuous culture according to the method described by Radfar et al. (2009) . The parasite was cultured in complete medium in T25 flasks and incubated at 37 o C with 5% CO 2 . Parasitaemia was maintained at less than 10%. Culture medium was changed every 24 h and blood smear slides prepared to monitor parasitaemia levels. (Andoh et al. 2000) . The transformant was grown in 25 mL of SC-Ura broth medium with shaking at 180 rpm and incubated at 37°C for 48 h. A total of 400 μL culture was inoculated into 100 mL of screening medium (0.67% yeast nitrogen base without amino acids and ammonium sulphate, 0.5% ammonium sulphate, 2% D(+)-glucose anhydrate, 1 mL each of 0.03 mg/mL of adenine (hemisulphate salt), 0.03 mg/mL of L-tryptophan, 0.03 mg/mL of L-leucine, 0.03 mg/mL of L-histidine and 1.5% bacteriological agar, pH5.6). The medium was poured into petri dishes to solidify at room temperature. Paper disc diffusion assays were performed in the presence and absence of G. procumbens aqueous extract. Twenty microliters of 100 mg/mL extract was impregnated onto a Whatmann paper disc. The discs were prepared in two replicates and arranged onto the two different yeast culture media. Plates were incubated at both permissive (25°C) and high (37°C) temperatures. A Streptomycete previously identified toxic to the yeast, H7667 was used as the positive control in the assay (Cheenpracha et al. 2009 ). Growth was scored after 5 days.
BACTERIA
ANTI-MALARIAL ACTIVITY IN VITRO
ANTI-PLASMODIAL ASSAY G. procumbens aqueous extract was assessed for antiplasmodial activity in vitro against P. falciparum 3D7 using parasite lactate dehydrogenase (pLDH) method (Nkhoma et al. 2007 ). Chloroquine diphosphate, G. procumbens aqueous extract and kaempferol were each dissolved in culture medium at concentrations of 10 mg/mL and further serially diluted to eight descending concentrations ranging from 2000 to 0.0002 μg/mL. Asynchronous culture with parasitaemia of 2.5% and haematocrit of 3% were suspended in culture medium and aliquoted into 96-well plates preloaded with 1000 to 0.0001 μg/mL final concentrations of test samples and final haematocrit of 1.5%. All tests were performed in triplicates. The plates were incubated at 37 o C with 5% CO 2 for 48 h. After the incubation period, the plates were stored frozen at -20 o C overnight, thawed the next day and subjected to two more freeze-thaw cycles to lyse the red blood cells. In a fresh 96-well plate, 100 μL of Malstat reagent (13 mg/mL Tris-HCl (pH9.0), 20 mg/mL lithium L-lactate, 0.66 mg/mL APAD and 0.2% Triton X-100) and 25 μL of NBT/PES solution (1.6 mg/mL of nitroblue tetrazolium (NBT) and 0.1 mg/mL of phenazine ethosulphate (PES)) were added to each well. Following the freeze-thaw cycles, parasite culture in each well was resuspended and 15 μL of the culture transferred to the corresponding well of the Malstat plate. Absorbance was measured at 650 nm after 1 h of incubation at room temperature in the dark using a microplate reader (Fluostar Optima, Germany). IC 50 values were calculated using GraphPad Prism 6.
IN VIVO FOUR-DAY SUPPRESSIVE TEST
Male ICR mice (n=8) were intraperitoneally injected with an inoculum of 1 × 10 7 P. berghei-infected erythrocytes on day 0. Three hours after infection, P. berghei-infected mice were intraperitoneally administered with G. procumbens aqueous extract (250 mg/kg b.w.), chloroquine (10 mg/ kg b.w.) or 0.9% NaCl. Injections were carried out for four consecutive days from day 0 to day 3. Parasitaemia was determined on day 4 by preparing blood smear slides using tail blood of the animals. Four-day suppressive test was also performed using 5 mg/kg b.w. kaempferol administered as described above. Chemosuppression was calculated and survival time in days recorded.
ANTI-INFLAMMATORY ACTIVITY ANIMAL INFECTION STUDIES (ACUTE MELIOIDOSIS MOUSE MODEL)
Male BALB/c mice (n=9) were intraperitoneally injected with B. pseudomallei (7.26 × 10 4 CFU) suspended in 200 μL phosphate buffered saline (PBS). To evaluate the effects of G. procumbens on the survivability of mice, B. pseudomallei-infected mice were administered intraperitoneally with G. procumbens aqueous extract (50 mg/kg b.w.) or 0.9% NaCl one day pre-infection. Survivability test was also performed using 10 mg/kg b.w. kaempferol administered as described above. Survivability of mice was monitored over a duration of 14 days.
BACTERIAL LOAD
Male BALB/c mice (n=3) were infected with B. pseudomallei (7.26 × 10 4 CFU) and subsequently treated with 50 mg/ kg b.w. G. procumbens aqueous extract at one day preinfection. The control group of mice (n=3) were only infected with B. pseudomallei. Three mice from each group (n=3) were euthanised at days 1, 2, 3, and 4. Liver organs were excised for the test and processed as described by Leakey et al. (1998) . In brief, liver was homogenised in PBS pH7.4, containing 0.14 M NaCl, 2.7 mM KCl, 0.01 M Na 2 HPO 4 and 1.7 mM KH 2 PO 4 . Tissue homogenates were serially diluted with PBS, spotted onto Ashdown agar and total bacteria in the samples determined as CFU.
WESTERN ANALYSIS
Liver organs were excised from malaria and acute melioidosis experimental animals, washed with icecold PBS and blot-dried with Whatman paper. Protein extraction was carried out as described by Lee (2007) . Briefly, liver organs were homogenised on ice in extraction buffer containing 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl pH8.0, supplemented with protease inhibitors (5 mM EDTA, 1 mM EGTA, 1 mM PMSF, 2 μg/mL aprotinin and 1 μg/mL leupeptin) and phosphatase inhibitors (5 mM NaF and 1 mM Na 3 VO 4 ). Samples were then centrifuged at 20000 g for 20 min at 4ºC. Protein concentrations of all test samples were first determined as described by Bradford (1976) . Each protein sample was diluted with 1:1 (w/v) sample buffer containing 0.5 M Tris-HCl, pH 6.8, glycerol, 10% SDS, 5% β-mercaptoethanol and 0.5% bromophenol blue for protein separation by SDS-PAGE on 12% resolving gel (Laemmli 1970) . Protein was electro-transferred (Invitrogen, Novex® Semi-Dry Blotter SD1000 Carlsbad, California) onto nitrocellulose membranes and probed with specific primary antibodies for GSK3β or phosphorylated GSK3β (Ser9) (Cell Signaling Technology, USA), followed by incubation with HRP-conjugated IgG as secondary antibodies. Detection of immunoreactive proteins was carried out using ECL western blotting detection reagents (Pierce, USA). Primary antibody for β-actin was used to check for consistent protein loadings.
CYTOKINE ASSAY
Male BALB/c mice (n=5) were intraperitoneally treated with 50 mg/kg b.w. G. procumbens aqueous extract at one day pre-infection and subsequently infected with B. pseudomallei (7.26 × 10 4 CFU). The control group of mice were only infected with B. pseudomallei. At day 1 post-infection, mice were euthanised and liver organs excised. Blood was collected by cardiac puncture. Blood was allowed to clot at room temperature and was then centrifuged at 2000 g for 15 min to obtain sera. Organs were processed as described by Phelan et al. (2002) . Briefly, the organs were homogenised in a buffer containing a protease-inhibitor combination (1 mM PMSF, 1 μg/mL pepstatin A and 1 μg/mL leupeptin in phosphate buffered saline solution, pH7.2), 0.05% sodium azide and 0.5% Triton X-100 in the ratio of 100 mg tissue per mL. The homogenates were then subjected to three rounds of freeze-thaw cycles and incubated at 4ºC for 1 h. The final homogenate was then centrifuged at 120000 g for 30 min and the resultant supernatant and sera used for determination of TNF-α, IFN-γ, and IL-10 levels using cytokine ELISA kits (Qiagen, Germany).
STATISTICAL ANALYSIS
All data were analysed using GraphPad Prism 6 analysis software (GraphPad, San Diego, CA, USA). Log rank and t-test were used to evaluate statistical significance between groups at P value of <0.05.
RESULTS
G. PROCUMBENS DISPLAYED GSK3Β-INHIBITORY ACTIVITY
A yeast-based assay was performed to evaluate anti-GSK3 activity in G. procumbens aqueous extract. G. procumbens exhibited inhibitory activity against mammalian GSK3β transformed into yeast, with a zone of inhibition (ZOI) value of 8 mm at 37°C at 2 mg/disc (Table 1) . The positive control, Streptomycetes H7667 showed ZOI of 10 mm at 37°C at 4 mg/disc. Table  2 ). Test samples with IC 50 < 10 μg/mL are classified as exhibiting high anti-plasmodial activity; samples with 10 < IC 50 < 50 μg/mL as medium activity; those with 50 < IC 50 < 100 μg/mL as low activity; and IC 50 > 100 μg/mL as no activity (Kvist et al. 2006; Rasoanaivo et al. 2004 ). Accordingly, G. procumbens and kaempferol showed medium and low anti-plasmodial activities, respectively.
G. PROCUMBENS AND KAEMPFEROL EACH INHIBITED PARASITAEMIA DEVELOPMENT AND PROLONGED SURVIVABILITY OF P. BERGHEI-INFECTED MICE
Administration of 250 mg/kg b.w. of G. procumbens resulted in dose-dependent chemosuppressive activities resulting in 87.09±4.32% suppression of parasitaemia compared with non-treated control mice on day 4 (Table  3) . Administration of 5 mg/kg b.w. of kaempferol inhibited parasitaemia development in P. berghei-infected mice by 60.27±3.20% compared to non-treated control mice on day 4 (Table 4) . Chloroquine treatment at 10 mg/kg b.w.
showed parasite clearance with 100% chemosuppression on day 4. According to Gathirwa et al. (2008) , a test sample capable of causing more than 60% chemosuppression is classified as highly active, displaying very good antimalarial activity. G. procumbens aqueous extract (250 mg/ kg b.w.) and kaempferol (5 mg/kg b.w.) resulted in more than 60% chemosuppression, hence both displayed very good anti-malarial activities. P. berghei-infected mice treated with 250 mg/kg b.w. G. procumbens aqueous extract showed prolonged survivability compared with non-treated infected mice. More than 50% of the animals treated with G. procumbens extract at 250 mg/kg b.w. survived till the end of the experiment (day 28). As comparison, median survival time of 16 days was obtained for non-treated infected mice (Figure 1(a) ). Mice administered with kaempferol at dosages of 5 mg/kg b.w. displayed median survival time of 25 days. As comparison, median survival time (Leakey et al. 1998) . Optimally, administration of 50 mg/kg b.w. G. procumbens at one day pre-infection significantly (p<0.05) improved survivability of infected mice by 33% (Figure 2(a) ). Survivability test with kaempferol also showed that administration of 10 mg/ kg b.w. of the compound at one day pre-infection conferred improved survivability (33%) to B. pseudomallei-infected mice (Figure 2(b) pseudomallei -infected mice increased drastically from day 1 to 4 following infection (Figure 3) . However, in G. procumbens-treated infected mice, hepatic bacterial loads were not significantly lowered within the same timeframe compared with non-treated control thus suggesting (a) (b) FIGURE 2. Kaplan-Meier survival curve for B. pseudomallei-infected mice with and without administration of (a) G. procumbens aqueous extract or (b) kaempferol at one day pre-infection. Significant difference between tested groups and control infected group was evaluated at p<0.05 (*) FIGURE 3. Bacterial load on day 1 to day 4 post-infection in liver of mice administered with B. pseudomallei (7.26 × 10 4 CFU) with or without G. procumbens aqueous extract treatment at one day pre-infection. Data presented as mean ± S.D. that proliferation of the bacteria was not affected by G. procumbens administration.
G. PROCUMBENS AND KAEMPFEROL EACH RESULTED IN INCREASED SER9 PHOSPHORYLATION OF GSK3β
Administration of G. procumbens into P. berghei-infected mice resulted in increased phosphorylation of liver GSK3β (Ser9) by 2.32-fold compared with non-treated P. bergheiinfected mice (Figure 4) . It is noteworthy that increased phosphorylation was also observed in liver of kaempferoladministered animals (2.05-fold), thus suggesting the anti-malarial effects of G. procumbens and kaempferol described earlier involve phosphorylation and inhibition of GSK3β. Administration of B. pseudomallei-infected mice with G. procumbens or kaempferol increased phosphorylation of GSK3β in mice liver by 3.33-and 3.99-fold, respectively, compared with non-treated infected mice ( Figure 5 ). These results implicate positive correlation between survival advantage conferred by G. procumbens and kaempferol and the phosphorylation of GSK3β. The findings showed that anti-malarial and anti-inflammatory activities of G. procumbens and kaempferol involve inhibition of GSK3β.
ADMINISTRATION OF G. PROCUMBENS RESULTED IN REDUCTION OF PRO-INFLAMMATORY CYTOKINES AND ELEVATION OF ANTI-INFLAMMATORY CYTOKINES
The levels of pro-inflammatory cytokines (TNF-α and IFN-γ) and anti-inflammatory cytokine (IL-10) in liver and serum of B. pseudomallei-infected mice were significantly elevated by 1.51-to 13.5-fold compared with noninfected animals ( Figure 6 ). Levels of TNF-α and IFN-γ in liver and serum were lowered upon administration of G. procumbens in infected animals. Serum level of IL-10 was observed to be raised (1.55-fold) during B. pseudomallei infection. In infected animals administered with G. procumbens, TNF-α and IFN-γ levels were lowered whilst IL-10 was further elevated. Here we suggest that the improved survivability of the G. procumbenstreated infected animals described earlier to be related to the modulatory effects of the extract on inflammatory cytokines. 
DISCUSSION
Findings from the present study pertaining to GSK3β phosphorylation stated in samples, acquired from two different experimental infection models for malaria and melioidosis indicate that pharmacological activities of G. procumbens with respect to anti-malarial and antiinflammatory effects are mediated through inhibition of GSK3β. Even though preliminary studies in our laboratory using a yeast-based assay (Chong et al. 2012) detected the presence of GSK3-inhibitory activity in the aqueous extract prepared from G. procumbens (unpublished data), the GSK3β phosphorylation observed could be attributed to phosphorylation by an upstream kinase (e.g. Akt) activated during host inflammatory signaling response. Thus inhibition of GSK3β seems to be the common underlying factor associated with the antimalarial and anti-inflammatory activities exhibited by this plant. Intraperitoneal injections were employed for the administration of test compounds and extracts as commonly described for anti-malarial screening (Baptista et al. 2010; Nunes et al. 2009 ) and bacterial infection (Tay et al. 2012; Zhang et al. 2009 ) studies. Identification of P. falciparum gene homologue of GSK3β (PfGSK3β) (Droucheau et al. 2004 ) has led to current efforts to exploit GSK3 (and other kinases) as a drug target for malaria. Homologues of GSK3 have also been identified in other Apicomplexan parasites, Leishmania donovani (Xingi et al. 2009 ) and Trypanosoma brucei (Ojo et al. 2008 ). Nurul Aiezzah et al. (2010 was the first to report chemosuppressive effects of a GSK3 inhibitor (LiCl) in a murine model of malarial infection. The present study confirmed our previous findings on suppression of plasmodial development and prolonged survivability of P. berghei-infected mice treated with G. procumbens (Visalini et al. 2012) . We now show that treatment of P. berghei-infected mice with the G. procumbens aqueous extract caused Ser9 phosphorylation of liver GSK3β. Thus inhibition of GSK3β is a plausible mechanism in the anti-malarial property of G. procumbens. Similar chemosuppressive effects were observed with kaempferol concomitantly resulting in Ser9 phosphorylation of liver GSK3β. The data obtained suggested that kaempferol is the likely anti-malarial bioactive compound in G. procumbens although this does not exclude the possibility that other bioactive components may also be involved. At this juncture, GSK3β inhibition appears to be the molecular basis of the anti-malarial effect of G. procumbens attributed to kaempferol.
In addition to the anti-malarial studies of G. procumbens and kaempferol, we extended our investigation to evaluate the effects of G. procumbens and kaempferol on the modulation of inflammatory response during bacterial infection. For this purpose, we employed an acute melioidosis infection model using B. pseudomallei-infected mice. Treatment with G. procumbens and kaempferol each not only increased survivability of B. pseudomalleiinfected mice but also concomitantly caused inhibition of GSK3β and modulated the pro-and anti-inflammatory cytokine levels. Thus our findings corroborate current understanding that GSK3β is a crucial mediator of the innate immune system response to bacterial infections (Wang et al. 2014) . In an earlier report (Tay et al. 2012) , we showed that B. pseudomallei infection-mediated production of pro-inflammatory cytokines (TNF-α, were significantly decreased upon GSK3β inhibition elicited by LiCl treatment. In contrast, GSK3β inhibition increased serum levels of anti-inflammatory cytokines (IL-10 and IL-1Ra). It is noteworthy that the results obtained from our studies showed no significant difference between IL-10 levels in the liver of G. procumbens-administered infected mice and non-treated infected mice. Similar results were reported in F. tularensis infection where no significant increase in IL-10 levels was observed in mice treated with the GSK3 inhibitor, lithium ), possibly related to the presence of unidentified molecules in vivo that limit the IL-10 response (Zhang et al. 2005 ). More importantly, in our experiments, the administration of G. procumbens significantly decreased pro-inflammatory cytokines (TNF-α and IFN-γ) in both liver and serum of B. pseudomallei-infected animals. Inhibition of GSK3β in S. typhimurium (Duan et al. 2007 ) and F. tularensis ) infections inhibited pro-inflammatory cytokine production whilst increasing production of anti-inflammatory cytokines. In addition, it has also been reported that administration of GSK3 inhibitors protected host from endotoxic shock caused by Escherichia coli (Ko et al. 2010) . Taken together, as in the case of the antimalarial effects explained earlier, the anti-inflammatory effect of G. procumbens involved GSK3β inhibition and may also be attributed to its bioactive component, kaempferol.
Phyto-constituents previously identified in G. procumbens potentially responsible for blood glucoselowering activity include kaempferol, astragalin (kaempferol-3-glucoside), quercetin (kaempferol-3-orutinoside) and rutin (quercetin-3-O-rutinoside), shown to mimic or improve insulin action at the cellular level (Hassan et al. 2010) . More importantly, the present study showed that kaempferol, one of the bioactive components of G. procumbens (Akowuah et al. 2002; Chong et al. 2012) , can result in increased phosphorylation of GSK3β in malarial and B. pseudomallei infection. To the best of our knowledge, the effect of kaempferol on GSK3 phosphorylation in malarial and B. pseudomallei infection has not been previously described.
GSK3 has been established to play important roles in host response to viral, fungal and parasitic infections, including malaria (Wang et al. 2014 ). Inhibition of GSK3β as a consequence of treatment with G. procumbens aqueous extract exhibited chemosuppressive effects, prolonged survivability in P. berghei-infected mice and improved survivability of B. pseudomallei-infected animals. Similar outcomes were observed with kaempferol treatment for the three effects described. Kaempferol has been shown previously to exhibit anti-plasmodial activities (Lehane & Saliba 2008) . The presence of kaempferol in G. procumbens thus may contribute in part to the observed anti-malarial and anti-inflammatory effects. Evidence obtained from the present study showed that the pharmacological activities described here of G. procumbens (and kaempferol) are mediated through inhibition of GSK3β; and provides a basis in part for the health benefits of kaempferol-containing plants.
CONCLUSION
Findings from the present study implicate GSK3β as a common factor in the anti-malarial and anti-inflammatory effects of G. procumbens. GSK3β is also well-known for its central role in the regulation of pathogeninduced inflammatory responses. The bioactivities of G. procumbens may in part be attributed to kaempferol. Thus, pharmacological effects seen here in G. procumbens involved GSK3β inhibition and our findings provide scientific evidence on the documented traditional use of G. procumbens as remedy for inflammation-related diseases.
